BLRBIO

Our next-generation therapeutics are designed to transform patient outcomes in diseases of high unmet medical needs. BLR Bio is a privately held biotechnology company committed to the discovery and development of transformational therapeutics that combine the best features of both biologic and small molecule drug classes into easy to manufacture and deliver, small peptides with high target specificity... BLR Bio is a privately held biotechnology company committed to the discovery and development of transformational biologics and diagnostics for the treatment of Cancer and a broad spectrum of serious Fibrotic Diseases (with a focus on orphan and specialty fibrotic diseases)... Supporting our therapeutic activities, we also have a paired diagnostic biomarker program that will provide unique opportunities in personalized medicine in these target diseases.